| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |